Most men notice weight gain long before they act on it. The trousers that no longer fit, the energy that used to be there, get filed under later. The reason that matters is that the changes weight gain sets off, in blood fats, blood sugar and the liver, are silent for years and show only on a blood test. Blood pressure is the other silent one, and it needs a cuff.
This article explains why the delay happens, what it costs, and what knowing your numbers changes.
In this article
Why men are less likely to seek help
The Government's men's health strategy for England, published on 19 November 2025, says it plainly: men can be less likely to seek help and more likely to suffer in silence. [1] The pattern shows up in the data. An analysis of UK general practice records found men consulting a GP about a third less often than women, with the gap widest in working age. [2] In the last published breakdown of the NHS Health Check, 44% of eligible women attended against 38% of men. [3]
This is not a character flaw. From an early age, men absorb the message that managing discomfort quietly is a form of strength, and weight is visible and socially loaded in a way most health problems are not. So most men adapt instead of asking. A larger shirt size. Tiredness put down to work, poor sleep put down to stress, reduced fitness put down to age. All of those may be partly true. They are also the early shape of a metabolic picture that tends to worsen if left alone.
A 2026 Anglia Ruskin University study that ran focus groups with 24 men with experience of being overweight found they saw dieting as restriction and denial, regarded weight-loss programmes as female-centric, and responded to quick wins and friendly competition rather than to a diet. [4] That is a small qualitative study, but it matches what most men will recognise.
The scale of the problem in England
In the Health Survey for England 2022, 67% of men were overweight or living with obesity, against 61% of women. [5] The British Heart Foundation estimates that, if nothing changes, nearly 170,000 lives could be lost to cardiovascular disease linked to excess weight in England between 2026 and 2035, around 45 a day, and that about 1 in 9 cardiovascular deaths in England each year is already attributable to excess weight. [6]
These are population figures. Behind them are men whose conditions had detectable, addressable roots years earlier.
What happens inside when weight gain goes unaddressed
Cardiovascular risk
Excess weight, particularly fat stored inside the abdomen, is associated with higher blood pressure, raised triglycerides, lower HDL cholesterol and extra strain on the heart. Its signature on a blood test is not usually high LDL; it is the triglyceride and HDL pattern, with LDL often near normal. [7] None of this produces symptoms. You can carry significantly raised cardiovascular risk and feel fine, which is why it goes undetected.
Metabolic syndrome
Visceral fat is metabolically active in ways that fat under the skin is not. It is tied to insulin resistance, and over time contributes to the cluster called metabolic syndrome: a large waist, raised blood pressure, high triglycerides, low HDL and raised blood sugar. Three or more of the five is the standard definition, and the cluster is associated with about 2.3 times the risk of cardiovascular disease and roughly 3.5 to 5 times the risk of type 2 diabetes, depending on the definition used. [8] [14] See Metabolic syndrome in men: symptoms, causes and what to do about it.
Hormonal change
Fat tissue contains the enzyme aromatase, which converts testosterone into oestradiol. As body fat rises, so does that conversion, and excess fat also disrupts the signals from the brain to the testes. Lower testosterone affects energy, mood, muscle and sex drive, and men often put those changes down to age. The NHS notes that late-onset hypogonadism occurs particularly in men who are obese or have type 2 diabetes. [9] See Low testosterone and weight gain: the overlooked connection in men.
Liver and thyroid
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease, is fat building up inside the liver. Liver UK (formerly the British Liver Trust) estimates it affects about 1 in 4 adults in the UK and links it to being overweight and to type 2 diabetes; it progresses silently. [10] The thyroid is a different case: an underactive thyroid causes a modest weight gain and tiredness that are easy to mistake for the picture above, which is why TSH is checked alongside the rest. [11] Neither tends to announce itself. Both show up on blood tests.
Why the GP barrier matters
Even men who know something is wrong often do not act. In Health Foundation and Ipsos polling carried out in December 2025, nearly half of the public (48%) said they had delayed or avoided contacting their GP practice about a health concern in the past year, with reasons ranging from choosing to manage the problem themselves to not expecting a suitable appointment. [12] Describing vague symptoms (tiredness, weight gain, less energy) in a short appointment feels inadequate before you have started.
There is also the expectation of being told to eat less and move more. That advice is not wrong, and NICE guidance still starts with lifestyle change. [13] But on its own it rarely accounts for the specific metabolic picture driving the problem, and most men who have tried know it. The result is a loop where the barrier feels high, the expected return feels low, and nothing changes. The barrier is worth pushing through anyway: your GP is the route to the NHS Health Check, to a fasting blood test or hormone panel if you need one, and to specialist care if your results call for it.
What knowing your blood markers changes
Most of what is described above, raised blood fats, insulin resistance, early liver strain, a thyroid problem, is invisible without a blood test. You cannot feel your triglycerides. You cannot tell from how you feel whether your HbA1c is creeping upwards. Measuring replaces guesswork with a starting point, and gives you and a clinician something specific to act on.
HeMed is a clinician-led weight loss and metabolic health service for men in the UK, built around an at-home blood test. The needle-free kit measures 10 markers across heart, liver, blood sugar and thyroid; a clinician reviews every result and builds any plan around what the test shows. Hormone and fasting tests are not part of the panel and are arranged through your GP. The test is not a replacement for seeing your GP, and if a result needs GP-level attention that is a reason to make the appointment. See What we test.
When is the right time to act?
Earlier than most men do. Weight gain that has sat around the middle for several years is a metabolic signal, not a cosmetic one. The useful question is not whether to address it but how, in a way that accounts for your own numbers rather than a general assumption. Measure your waist against half your height, get your blood pressure and blood fats checked, and go from there. Everything else follows from knowing where you stand.
Frequently asked questions
Why do men tend to ignore weight gain for longer than women?
Men are less likely to seek help for health concerns generally, a pattern the Government's 2025 men's health strategy for England describes directly and that shows in lower GP consultation rates and lower NHS Health Check uptake. Weight also carries social weight for men, and the cultural expectation to manage problems quietly delays action until symptoms are hard to ignore.
Which health conditions are linked to unaddressed weight gain in men?
Excess weight, particularly abdominal fat, is associated with raised cardiovascular risk, insulin resistance and type 2 diabetes, metabolic syndrome, fatty liver disease (MASLD) and lower testosterone. These develop without obvious symptoms, which is why they often go undetected for years.
Can weight gain affect testosterone?
Yes. Fat tissue contains aromatase, which converts testosterone into oestradiol, and excess fat disrupts the brain's signals to the testes. Weight loss in men with obesity raises testosterone on average. If you suspect low testosterone, a morning blood test through your GP is the way to find out.
What are blood markers, and why do they matter for weight?
Blood markers are measurable indicators of how body systems are working: cholesterol and triglycerides for cardiovascular risk, HbA1c for blood sugar, ALT, AST and GGT for the liver, TSH for the thyroid. Together they show the metabolic effects of weight that symptoms alone cannot.
What does HeMed's at-home blood test measure?
10 markers across four areas: total cholesterol, LDL, HDL, triglycerides and the cholesterol ratio; the liver enzymes ALT, AST and GGT; HbA1c; and TSH. It is needle-free, done at home, and every result is reviewed by a clinician. It does not include testosterone or a fasting glucose test.
Is it worth acting on weight gain if I feel fine?
Yes. Raised blood pressure, insulin resistance and abnormal blood fats produce no symptoms in their early stages, and the NHS says high cholesterol can only be found with a blood test. Feeling fine is not the same as being metabolically well.
When should a man speak to a GP about weight gain?
If your waist is more than half your height, if you have a family history of cardiovascular disease or type 2 diabetes, or if you have not had your blood pressure and blood fats checked in the last few years. See a GP promptly for chest pain, breathlessness on exertion, excessive thirst or passing urine much more often.
HeMed provides clinician-led weight management. This page is general health information, not medical advice. If you are worried about symptoms, speak to your GP, or use NHS 111.
Next step: see what the HeMed blood test measures.
Sources (14)
- Department of Health and Social Care, "Men's health: a strategic vision for England", CP 1432, published 19 November 2025. gov.uk/government/publications/mens-health-strategy-for-england. Accessed 5 October 2026.
- Wang Y and colleagues. "Do men consult less than women? An analysis of routinely collected UK general practice data." BMJ Open 2013;3:e003320. doi.org/10.1136/bmjopen-2013-003320. Accessed 5 October 2026.
- Healthwatch England, "Time to get serious about men's NHS Health Checks", 18 September 2025, citing the 2017 to 2018 Public Health England uptake breakdown. healthwatch.co.uk. Accessed 5 October 2026.
- Cortnage M, Lillis J, Roberts J. "Male perceptions and experiences of weight loss initiatives: considerations for sustainable lifestyle practices." PLOS One 2026;21(8), published 26 August 2026. pmc.ncbi.nlm.nih.gov/articles/PMC13514000. Accessed 5 October 2026.
- NHS England Digital, "Health Survey for England 2022, part 2: adult overweight and obesity". digital.nhs.uk. Accessed 5 October 2026.
- British Heart Foundation, "170,000 lives at risk over next decade from weight-linked cardiovascular disease", June 2026. bhf.org.uk. Accessed 5 October 2026.
- Feingold KR. "Obesity and dyslipidemia." In: Endotext, MDText.com, updated 2023. ncbi.nlm.nih.gov/books/NBK305895. Accessed 5 October 2026.
- Mottillo S and colleagues. "The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis." Journal of the American College of Cardiology 2010;56(14):1113 to 1132. doi.org/10.1016/j.jacc.2010.05.034. Accessed 5 October 2026.
- NHS, "The 'male menopause'", page last reviewed 13 October 2022. nhs.uk/conditions/male-menopause. Accessed 5 October 2026.
- Liver UK (formerly the British Liver Trust), "Metabolic dysfunction-associated steatotic liver disease (MASLD)". liveruk.org/about-liver-disease/conditions/masld. Accessed 5 October 2026.
- American Thyroid Association, "Thyroid and weight". thyroid.org/thyroid-and-weight. Accessed 5 October 2026.
- The Health Foundation and Ipsos, "Half of the public avoided contacting their GP about a health concern, new polling shows", published 25 February 2026 (fieldwork 4 to 10 December 2025). health.org.uk. Accessed 5 October 2026.
- NICE, "Overweight and obesity management", NG246, January 2025. nice.org.uk/guidance/ng246. Accessed 5 October 2026.
- Ford ES, Li C, Sattar N. "Metabolic syndrome and incident diabetes: current state of the evidence." Diabetes Care 2008;31(9):1898 to 1904. doi.org/10.2337/dc08-0423. Accessed 5 October 2026.
Numbered markers in the page text link to these entries. Statistics describe populations, not any one person’s results.